Ati cautat: deficit de medici
CMR solicita transparentizarea informatiilor care fundamenteaza CoCa si normele
Protocol terapeutic: A16AX16 – GIVOSIRAN (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: A16AX09 – GLYCEROLI PHENYLBUTYRAS (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: R07AX02 – DCI IVACAFTORUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N07XX07 – DCI FAMPRIDINE (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: M09AX01 – DCI ACIDUM HIALURONICUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XX24 – DCI PEGASPARGASUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: J05AX18 – DCI LETERMOVIRUM (forma orală) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: H05AA03 – DCI PARATHYROID HORMONE (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: DCI FOLLITROPINUM ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
